Cargando…

Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial

Detalles Bibliográficos
Autores principales: Bhat, Swati, Das, Liza, Maheshwari, Deep, Badal, Darshan, Sarkar, Roman, Gupta, Madhu, Pandav, Surinder Singh, Padhi, Bijaya Kumar, Bhadada, Sanjay Kumar, Holick, Michael F., Dutta, Pinaki, Sachdeva, Naresh, Marwaha, Raman Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008192/
https://www.ncbi.nlm.nih.gov/pubmed/36889512
http://dx.doi.org/10.1016/j.jinf.2023.03.004
_version_ 1784905702829981696
author Bhat, Swati
Das, Liza
Maheshwari, Deep
Badal, Darshan
Sarkar, Roman
Gupta, Madhu
Pandav, Surinder Singh
Padhi, Bijaya Kumar
Bhadada, Sanjay Kumar
Holick, Michael F.
Dutta, Pinaki
Sachdeva, Naresh
Marwaha, Raman Kumar
author_facet Bhat, Swati
Das, Liza
Maheshwari, Deep
Badal, Darshan
Sarkar, Roman
Gupta, Madhu
Pandav, Surinder Singh
Padhi, Bijaya Kumar
Bhadada, Sanjay Kumar
Holick, Michael F.
Dutta, Pinaki
Sachdeva, Naresh
Marwaha, Raman Kumar
author_sort Bhat, Swati
collection PubMed
description
format Online
Article
Text
id pubmed-10008192
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100081922023-03-13 Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial Bhat, Swati Das, Liza Maheshwari, Deep Badal, Darshan Sarkar, Roman Gupta, Madhu Pandav, Surinder Singh Padhi, Bijaya Kumar Bhadada, Sanjay Kumar Holick, Michael F. Dutta, Pinaki Sachdeva, Naresh Marwaha, Raman Kumar J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-05 2023-03-06 /pmc/articles/PMC10008192/ /pubmed/36889512 http://dx.doi.org/10.1016/j.jinf.2023.03.004 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Bhat, Swati
Das, Liza
Maheshwari, Deep
Badal, Darshan
Sarkar, Roman
Gupta, Madhu
Pandav, Surinder Singh
Padhi, Bijaya Kumar
Bhadada, Sanjay Kumar
Holick, Michael F.
Dutta, Pinaki
Sachdeva, Naresh
Marwaha, Raman Kumar
Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title_full Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title_fullStr Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title_full_unstemmed Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title_short Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
title_sort effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the chadox1 ncov-19 vaccine: a prospective open-label, placebo-controlled, clinical trial
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008192/
https://www.ncbi.nlm.nih.gov/pubmed/36889512
http://dx.doi.org/10.1016/j.jinf.2023.03.004
work_keys_str_mv AT bhatswati effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT dasliza effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT maheshwarideep effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT badaldarshan effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT sarkarroman effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT guptamadhu effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT pandavsurindersingh effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT padhibijayakumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT bhadadasanjaykumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT holickmichaelf effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT duttapinaki effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT sachdevanaresh effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial
AT marwaharamankumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial